首页> 中文期刊> 《中国医药科学》 >布地奈德和盐酸氨溴索联合使用超声雾化吸入治疗婴幼儿毛细支气管炎的疗效观察

布地奈德和盐酸氨溴索联合使用超声雾化吸入治疗婴幼儿毛细支气管炎的疗效观察

         

摘要

Objective To study the clinical effect of combining use of budesonide and hydrochloric acid ammonia bromine using ultrasonic atomization on treatment of infantile capillary bronchitis. Methods 80 cases of patients in our hospital were selected,randomly divided into experimental group and control group,each 40 cases,the experimental group were given basic treatment plus budesonide and ambroxol hydrochloride using ultrasonic atomizing inhalation,Compared the disappeared time of clinical symptoms and signs and the cure rate of the two groups. Results The time of clinical symptoms and signs in the experimental group were shorter than that of the observation group,the cure rate in the experimental group was significantly higher than the control group. Conclusion Using budesonide and hydrochloric acid ammonia bromine with ultrasonic atomization inhalation on treatment of infantile capillary bronchitis,can effectively shorten the time of dyspnea,suppress wheezing (such as clinical symptoms and signs of time,and improve the cure rate.The clinical application of the treatment is safe and convenient,is worth to clinical promotion.%目的:探讨布地奈德和盐酸氨溴索合用使用超声雾化治疗婴幼儿毛细支气管炎的临床效果。方法选80例来我院就诊的患儿随机分为实验组和对照组,各40例,实验组在采取基础治疗外加用布地奈德+盐酸氨溴索使用超声雾化吸入治疗,对比两组患儿临床症状、体征消失时间以及治愈率。结果实验组临床症状、体征时间均比观察组时间短,并且治愈率也明显高于对照组。结论布地奈德和盐酸氨溴索联合使用超声雾化吸入治疗婴幼儿毛细支气管炎,可以有效缩短患儿呼吸困难、憋喘等临床症状和体征缓解时间,并且提高治愈率,对于临床应用安全方便,值得临床推广。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号